How to Help Your Patients Save Money on Flecainide: A Provider's Guide to Savings Programs

For most patients, generic flecainide is affordable — but not for everyone. Retail prices can exceed $90 per month without insurance, and patients on complex cardiac regimens may be juggling multiple high-cost medications. As a prescribing provider, knowing the savings landscape helps you prevent medication non-adherence driven by cost — which, in an antiarrhythmic patient, is a patient safety issue.

The Cost Landscape for Flecainide in 2026

Understanding the actual cost your patient faces requires knowing their insurance situation and the available discount options:

• Retail cash price (no discount): $22–$94/month depending on strength (100 mg is typically cheapest; 50 mg tends to be most expensive per tablet)
• With GoodRx or SingleCare: $11–$15/month (80–86% savings off retail)
• Insurance copay (Tier 1–2): $0–$20/month on most commercial plans; similar for Medicare Part D at Tier 1–2
• During insurance deductible period: Can be full retail price; consider directing patient to GoodRx instead of running insurance until deductible is met

Is There a Manufacturer Patient Assistance Program?

No. Since flecainide has been generic since 2004, there is no brand-name manufacturer patient assistance program (PAP). Manufacturer PAPs are almost exclusively available for brand-name drugs under patent. The original Tambocor manufacturer no longer actively markets the drug in the U.S.

For patients who need cost assistance, the third-party discount programs below are the most effective tools.

GoodRx and SingleCare: The Most Practical Tools

GoodRx and SingleCare are the most widely applicable savings tools for generic flecainide:

• GoodRx: As of 2026, GoodRx reduces generic flecainide to as low as $11.13/month. Available at CVS, Walgreens, Walmart, Kroger, and thousands of independents. Patients download the app or show the pharmacist a coupon code at pickup.
• SingleCare: Comparable savings (approximately $13.91 for 60 tablets). Works at most major chains.

Clinical note: When patients use GoodRx or SingleCare, the purchase is treated as a cash transaction — it does not apply to their insurance deductible or out-of-pocket maximum. For patients trying to meet their deductible, this may not be their best option. For patients below their deductible or uninsured, it is almost always the cheapest option.

Medicare Part D Strategies

For Medicare patients, generic flecainide is typically covered on Part D at Tier 1 or Tier 2, with copays of $0–$20 on most plans. Key points:

• 2026 out-of-pocket cap: $2,100/year for all covered Part D prescriptions. Patients on multiple cardiac medications may benefit from reaching this cap through their combination of drugs — something worth discussing with patients who are cost-burdened.
• Low-Income Subsidy (LIS/Extra Help): Medicare beneficiaries who qualify for the Low-Income Subsidy program pay minimal to no copay for covered medications including flecainide. Screen your eligible Medicare patients for LIS eligibility — it can dramatically reduce their medication burden.
• Plan comparison at open enrollment: Different Part D plans tier generics differently. Patients with several cardiac medications can use Medicare Plan Finder (medicare.gov) to compare total annual out-of-pocket costs across plans during open enrollment.

The 90-Day Supply Strategy: Cost and Supply Security in One

Prescribing a 90-day supply of flecainide is one of the most impactful things you can do for both patient cost and medication continuity:

• Lower per-tablet cost: Most insurance plans and discount programs offer lower per-unit pricing on 90-day fills. Mail-order programs often offer 3 months for the price of 2.
• Reduced pharmacy visit burden: Elderly or mobility-limited patients fill prescriptions less often.
• Buffer against pharmacy stock gaps: A 90-day supply provides a larger cushion when pharmacy stock issues occur — reducing the urgency of finding a refill.

Resources for Uninsured and Underinsured Patients

For patients without insurance or with high out-of-pocket costs:

• GoodRx (goodrx.com): Free discount card; lowest prices at various pharmacies. The fastest, simplest recommendation for uninsured patients.
• NeedyMeds (needymeds.org): Database of state pharmaceutical assistance programs, disease-specific programs, and charity care options.
• Federally Qualified Health Centers (FQHCs): FQHCs participate in the 340B drug pricing program and can dispense medications including generic flecainide at significantly reduced prices for eligible patients.
• State pharmaceutical assistance programs: Many states have programs for low-income Medicare patients or the general uninsured population. NeedyMeds is the best single resource for locating these.

Building Cost Conversations Into Your Workflow

Medication non-adherence due to cost is a preventable cause of arrhythmia recurrence. Integrating a brief cost check into your prescribing workflow — particularly at initiation and whenever a patient reports difficulty filling prescriptions — can prevent dangerous gaps.

A simple screening question — "Is cost a concern for you with this medication?" — at each visit can open the door to directing patients to available savings resources before they stop filling their prescription silently.

For help with availability (not just cost), your patients can use medfinder for Providers to locate which pharmacies near them have flecainide in stock — addressing both the cost and access dimensions of medication adherence.